Skip to main content
PMC home page
Journal of Medical Genetics logoLink to Journal of Medical Genetics
. 1995 Dec;32(12):942–945. doi: 10.1136/jmg.32.12.942

An extended Li-Fraumeni kindred with gastric carcinoma and a codon 175 mutation in TP53.

J M Varley 1, G McGown 1, M Thorncroft 1, K J Tricker 1, M D Teare 1, M F Santibanez-Koref 1, J Martin 1, J M Birch 1, D G Evans 1
PMCID: PMC1051773  PMID: 8825920

Abstract

We present an extended family with Li-Fraumeni syndrome characterised by gastric and breast carcinoma, glioma, sarcoma, and leukaemia. This family showed strong evidence of linkage to TP53, and three of four tumours analysed showed loss of the wild type allele. A codon 175 missense mutation was identified in exon 5 in all available affected subjects. Counselling, screening, and issues surrounding presymptomatic testing are discussed.

Full text

PDF
942

Images in this article

943Image
on p.943

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barnes D. M., Hanby A. M., Gillett C. E., Mohammed S., Hodgson S., Bobrow L. G., Leigh I. M., Purkis T., MacGeoch C., Spurr N. K. Abnormal expression of wild type p53 protein in normal cells of a cancer family patient. Lancet. 1992 Aug 1;340(8814):259–263. doi: 10.1016/0140-6736(92)92354-i. [DOI] [PubMed] [Google Scholar]
  2. Birch J. M., Hartley A. L., Tricker K. J., Prosser J., Condie A., Kelsey A. M., Harris M., Jones P. H., Binchy A., Crowther D. Prevalence and diversity of constitutional mutations in the p53 gene among 21 Li-Fraumeni families. Cancer Res. 1994 Mar 1;54(5):1298–1304. [PubMed] [Google Scholar]
  3. Birch J. M., Heighway J., Teare M. D., Kelsey A. M., Hartley A. L., Tricker K. J., Crowther D., Lane D. P., Santibáez-Koref M. F. Linkage studies in a Li-Fraumeni family with increased expression of p53 protein but no germline mutation in p53. Br J Cancer. 1994 Dec;70(6):1176–1181. doi: 10.1038/bjc.1994.468. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Birch J. M. Li-Fraumeni syndrome. Eur J Cancer. 1994;30A(13):1935–1941. doi: 10.1016/0959-8049(94)00383-g. [DOI] [PubMed] [Google Scholar]
  5. Birch J. M. The Li-Fraumeni cancer family syndrome. J Pathol. 1990 May;161(1):1–2. doi: 10.1002/path.1711610102. [DOI] [PubMed] [Google Scholar]
  6. Cady B. Familial bilateral cancer of the breast. Ann Surg. 1970 Aug;172(2):264–272. doi: 10.1097/00000658-197008000-00013. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Craufurd D., Dodge A., Kerzin-Storrar L., Harris R. Uptake of presymptomatic predictive testing for Huntington's disease. Lancet. 1989 Sep 9;2(8663):603–605. doi: 10.1016/s0140-6736(89)90722-8. [DOI] [PubMed] [Google Scholar]
  8. Frebourg T., Barbier N., Yan Y. X., Garber J. E., Dreyfus M., Fraumeni J., Jr, Li F. P., Friend S. H. Germ-line p53 mutations in 15 families with Li-Fraumeni syndrome. Am J Hum Genet. 1995 Mar;56(3):608–615. [PMC free article] [PubMed] [Google Scholar]
  9. Hartley A. L., Birch J. M., Marsden H. B., Harris M. Breast cancer risk in mothers of children with osteosarcoma and chondrosarcoma. Br J Cancer. 1986 Nov;54(5):819–823. doi: 10.1038/bjc.1986.245. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Jones M. H., Nakamura Y. Detection of loss of heterozygosity at the human TP53 locus using a dinucleotide repeat polymorphism. Genes Chromosomes Cancer. 1992 Jul;5(1):89–90. doi: 10.1002/gcc.2870050113. [DOI] [PubMed] [Google Scholar]
  11. KLUGE T. FAMILIAL CANCER OF THE COLON. Acta Chir Scand. 1964 Apr;127:392–398. [PubMed] [Google Scholar]
  12. Kemp C. J., Wheldon T., Balmain A. p53-deficient mice are extremely susceptible to radiation-induced tumorigenesis. Nat Genet. 1994 Sep;8(1):66–69. doi: 10.1038/ng0994-66. [DOI] [PubMed] [Google Scholar]
  13. Lewis A. C., Davison B. C. Familial ovarian cancer. Lancet. 1969 Aug 2;2(7614):235–237. doi: 10.1016/s0140-6736(69)90004-x. [DOI] [PubMed] [Google Scholar]
  14. Li F. P., Fraumeni J. F., Jr Soft-tissue sarcomas, breast cancer, and other neoplasms. A familial syndrome? Ann Intern Med. 1969 Oct;71(4):747–752. doi: 10.7326/0003-4819-71-4-747. [DOI] [PubMed] [Google Scholar]
  15. Li F. P., Garber J. E., Friend S. H., Strong L. C., Patenaude A. F., Juengst E. T., Reilly P. R., Correa P., Fraumeni J. F., Jr Recommendations on predictive testing for germ line p53 mutations among cancer-prone individuals. J Natl Cancer Inst. 1992 Aug 5;84(15):1156–1160. doi: 10.1093/jnci/84.15.1156. [DOI] [PubMed] [Google Scholar]
  16. Lustbader E. D., Williams W. R., Bondy M. L., Strom S., Strong L. C. Segregation analysis of cancer in families of childhood soft-tissue-sarcoma patients. Am J Hum Genet. 1992 Aug;51(2):344–356. [PMC free article] [PubMed] [Google Scholar]
  17. Lynch H. T., Harris R. E., Guirgis H. A., Maloney K., Carmody L. L., Lynch J. F. Familial association of breast/ovarian carcinoma. Cancer. 1978 Apr;41(4):1543–1549. doi: 10.1002/1097-0142(197804)41:4<1543::aid-cncr2820410444>3.0.co;2-y. [DOI] [PubMed] [Google Scholar]
  18. Lynch H. T., Lanspa S. J., Boman B. M., Smyrk T., Watson P., Lynch J. F., Lynch P. M., Cristofaro G., Bufo P., Tauro A. V. Hereditary nonpolyposis colorectal cancer--Lynch syndromes I and II. Gastroenterol Clin North Am. 1988 Dec;17(4):679–712. [PubMed] [Google Scholar]
  19. Lynch H. T., Shaw M. W., Magnuson C. W., Larsen A. L., Krush A. J. Hereditary factors in cancer. Study of two large midwestern kindreds. Arch Intern Med. 1966 Feb;117(2):206–212. [PubMed] [Google Scholar]
  20. Malkin D., Li F. P., Strong L. C., Fraumeni J. F., Jr, Nelson C. E., Kim D. H., Kassel J., Gryka M. A., Bischoff F. Z., Tainsky M. A. Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Science. 1990 Nov 30;250(4985):1233–1238. doi: 10.1126/science.1978757. [DOI] [PubMed] [Google Scholar]
  21. Pearson A. D., Craft A. W., Ratcliffe J. M., Birch J. M., Morris-Jones P., Roberts D. F. Two families with the Li-Fraumeni cancer family syndrome. J Med Genet. 1982 Oct;19(5):362–365. doi: 10.1136/jmg.19.5.362. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Santibáez-Koref M. F., Birch J. M., Hartley A. L., Jones P. H., Craft A. W., Eden T., Crowther D., Kelsey A. M., Harris M. p53 germline mutations in Li-Fraumeni syndrome. Lancet. 1991 Dec 14;338(8781):1490–1491. doi: 10.1016/0140-6736(91)92303-j. [DOI] [PubMed] [Google Scholar]
  23. Teare M. D., Rohde K., Santibáez Koref M. F. The use of loss of constitutional heterozygosity data to ascertain the location of predisposing genes in cancer families. J Med Genet. 1994 Jun;31(6):448–452. doi: 10.1136/jmg.31.6.448. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Toguchida J., Yamaguchi T., Dayton S. H., Beauchamp R. L., Herrera G. E., Ishizaki K., Yamamuro T., Meyers P. A., Little J. B., Sasaki M. S. Prevalence and spectrum of germline mutations of the p53 gene among patients with sarcoma. N Engl J Med. 1992 May 14;326(20):1301–1308. doi: 10.1056/NEJM199205143262001. [DOI] [PubMed] [Google Scholar]
  25. Went L. Ethical issues policy statement on Huntington's disease molecular genetics predictive test. International Huntington Association. World Federation of Neurology. J Med Genet. 1990 Jan;27(1):34–38. doi: 10.1136/jmg.27.1.34. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Medical Genetics are provided here courtesy of BMJ Publishing Group

RESOURCES